Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
184.31
+0.27 (0.15%)
Dec 5, 2025, 4:00 PM EST - Market closed
CRL Employees
Charles River Laboratories International had 20,100 employees as of December 31, 2024. The number of employees decreased by 1,700 or -7.80% compared to the previous year.
Employees
20,100
Change (1Y)
-1,700
Growth (1Y)
-7.80%
Revenue / Employee
$200,184
Profits / Employee
-$4,153
Market Cap
9.07B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 20,100 | -1,700 | -7.80% |
| Dec 31, 2023 | 21,800 | 400 | 1.87% |
| Dec 31, 2022 | 21,400 | 1,400 | 7.00% |
| Dec 25, 2021 | 20,000 | 1,600 | 8.70% |
| Dec 26, 2020 | 18,400 | 1,300 | 7.60% |
| Dec 28, 2019 | 17,100 | 2,400 | 16.33% |
| Dec 29, 2018 | 14,700 | 2,900 | 24.58% |
| Dec 30, 2017 | 11,800 | 800 | 7.27% |
| Dec 31, 2016 | 11,000 | 2,400 | 27.91% |
| Dec 26, 2015 | 8,600 | 700 | 8.86% |
| Dec 27, 2014 | 7,900 | 200 | 2.60% |
| Dec 28, 2013 | 7,700 | 500 | 6.94% |
| Dec 29, 2012 | 7,200 | 100 | 1.41% |
| Dec 31, 2011 | 7,100 | -400 | -5.33% |
| Dec 25, 2010 | 7,500 | -500 | -6.25% |
| Dec 26, 2009 | 8,000 | -1,000 | -11.11% |
| Dec 27, 2008 | 9,000 | 500 | 5.88% |
| Dec 29, 2007 | 8,500 | 500 | 6.25% |
| Dec 30, 2006 | 8,000 | -400 | -4.76% |
| Dec 31, 2005 | 8,400 | 400 | 5.00% |
| Dec 25, 2004 | 8,000 | 3,500 | 77.78% |
| Dec 27, 2003 | 4,500 | -500 | -10.00% |
| Dec 28, 2002 | 5,000 | 1,000 | 25.00% |
| Dec 29, 2001 | 4,000 | 500 | 14.29% |
| Dec 30, 2000 | 3,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CRL News
- 1 day ago - T. Rowe Price Transitions to Charles River's Enterprise Multi-Asset Investment Management Platform - Business Wire
- 2 days ago - Charles River Laboratories International, Inc. (CRL) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha
- 4 days ago - HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
- 4 days ago - Charles River Laboratories to Present at Evercore Healthcare Conference - Business Wire
- 14 days ago - Madison Small Cap Fund Q3 2025 Portfolio Activity - Seeking Alpha
- 17 days ago - Charles River Laboratories International, Inc. (CRL) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 17 days ago - SOLVE and Charles River Development Partner to Deliver Integrated Fixed Income Pricing for Investment Managers - Business Wire
- 18 days ago - Charles River Laboratories to Present at Jefferies Global Healthcare Conference - Business Wire